EKTERLY 300 mg/1
sebetralstat · TABLET · KalVista Pharmaceuticals Ltd
No Recall History
Plain English
EKTERLY is a tablet containing sebetralstat at 300 mg/1, taken oral. Manufactured by KalVista Pharmaceuticals Ltd.
Key Facts
- Brand Name
- EKTERLY
- Generic Name
- sebetralstat
- NDC Code (Product)
82928-300- Manufacturer
- KalVista Pharmaceuticals Ltd
- Strength
- 300 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA219301
- Drug Class
- Plasma Kallikrein Inhibitor [EPC]
- Marketing Start
- 07/03/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is EKTERLY used for?
EKTERLY contains sebetralstat. It is a tablet taken oral. Consult your doctor for specific uses.
Is EKTERLY a controlled substance?
EKTERLY is not classified as a controlled substance by the DEA.
What is the generic name for EKTERLY?
The generic name for EKTERLY is sebetralstat. There are no other listed brand versions of sebetralstat.
What is the NDC code for EKTERLY 300 mg/1?
The NDC (National Drug Code) for EKTERLY 300 mg/1 is 82928-300, listed by KalVista Pharmaceuticals Ltd.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)